This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Mar;121(2):195-8.

doi: 10.3810/pgm.2009.03.1993.

Review of ARBITER 2: extended-release niacin added to statin therapy slows the progression of atherosclerosis. Commentary

Affiliations

PMID: 19332979
DOI: 10.3810/pgm.2009.03.1993

Comment

Review of ARBITER 2: extended-release niacin added to statin therapy slows the progression of atherosclerosis. Commentary

Harold Bays. Postgrad Med. 2009 Mar.

. 2009 Mar;121(2):195-8.

doi: 10.3810/pgm.2009.03.1993.

Author

Affiliation

¹ Louisville Metabolic and Atherosclerotic Research Center, Louisville, KY 40213, USA. hbaysmd@aol.com

PMID: 19332979
DOI: 10.3810/pgm.2009.03.1993

No abstract available

PubMed Disclaimer

Comment on

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins.
Taylor AJ, Sullenberger LE, Lee HJ, Lee JK, Grace KA. Taylor AJ, et al. Circulation. 2004 Dec 7;110(23):3512-7. doi: 10.1161/01.CIR.0000148955.19792.8D. Epub 2004 Nov 10. Circulation. 2004. PMID: 15537681 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon